Showing 2511-2520 of 7016 results for "".
Combination Treatment Focused on a Noninvasive Approach to Facial Rejuvenation
https://reachmd.com/topics/energy-based-devices/combination-treatment-focused-on-a-noninvasive-approach-to-facial-rejuvenation/35420/A recipe for predictable skin rejuvenationEmpowering Epilepsy Care: Opportunities for Neurologists and Pediatricians in Managing Rare Epilepsy Syndromes
https://reachmd.com/diseases-diagnoses/epilepsy-seizures/empowering-epilepsy-care-opportunities-for-neurologists-and-pediatricians-in-managing-rare-epilepsy-syndromes-1/32193/Solutions for Aesthetic Practice
https://reachmd.com/topics/skincare/solutions-for-aesthetic-practice/35170/A look at new options to support aesthetic patientsSkincare for Skin Health: Counseling the Aesthetic Patient
https://reachmd.com/ma-supplements/2022-mar-apr-insert2/skincare-for-skin-health-counseling-the-aesthetic-patient/35159/Aesthetic physicians say being involved in patients’ decisions about everyday skincare regimens can boost skin quality and reinforce the aesthetic provider’s expertiseAn Overview of Topical Therapies for Managing Pediatric AD
https://reachmd.com/topics/atopic-dermatitis/an-overview-of-topical-ththerapies-for-managing-pediatric-ad/54375/Moisturization is foundational in AD management; no specific formulation has demonstrated superiority, and excessive bathing may worsen disease via increased transepidermal water loss. Topical corticosteroids and calcineurin inhibitors remain first-line due to strong efficacy data, cost-effectiveneOne Emergency Physician’s Cheat Sheet to COVID-19
https://reachmd.com/programs/covid-19-frontlines/one-emergency-physicians-cheat-sheet-to-covid-19/11376/Tune in to hear an anonymous account of unpredictable COVID-19 symptoms in a small-town emergency room.Expanding Treatment Options in PNH: Expert Approaches to Personalized Care
https://reachmd.com/programs/medical-industry-feature/pnh-expert-approaches-personalized-care/35651/Managing patients with paroxysmal nocturnal hemoglobinuria (PNH) is never a “one-size-fits-all” approach. With the emergence of a therapy like FABHALTA® (iptacopan), which delivers comprehensive control of intravascular and extravascular hemolysis, we have an option to offer to eligible adult patienThe Do’s and Don’ts of Managing Pediatric Hidradenitis Suppurativa
https://reachmd.com/topics/rare-disease/the-dos-and-donts-of-managing-pediatric-hidradenitis-suppurativa/54450/Pediatric HS is often underrecognized, especially in prepubertal children, leading to delayed treatment and preventable disease progression. Clinicians should adapt diagnostic criteria and proactively screen high-risk groups, such as patients with severe acne. Children with HS frequently have assocHarnessing the Immune Power: A Uniquely Designed PD-1 Inhibitor for Esophageal Cancer
https://reachmd.com/programs/project-oncology/harnessing-the-immune-power-a-uniquely-designed-pd-1-inhibitor-for-esophageal-cancer/35512/Esophageal cancer is the tenth most common cancer worldwide and the sixth most prevalent cause of death due to cancer, which is why having additional treatment options for this disease is crucial.1 One available option, tislelizumab plus platinum-based chemotherapy, was recently approved by the FDAClimate Change and Health: From Science to Practice
https://reachmd.com/programs/grand-rounds-nation/climate-change-and-health-from-science-to-practice/7268/Changes occurring in the world's climate pose significant threats to human health and well-being, and will have even greater impacts in the future. These threats are wide-ranging, including decreased air quality and increases in extreme weather events, wildfire, and illnesses transmitted by water, a